IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v576y2019i7785d10.1038_s41586-019-1758-2.html
   My bibliography  Save this article

Publisher Correction: Harnessing innate immunity in cancer therapy

Author

Listed:
  • Olivier Demaria

    (Innate Pharma)

  • Stéphanie Cornen

    (Innate Pharma)

  • Marc Daëron

    (Aix Marseille Université, INSERM, CNRS, Centre d’Immunologie de Marseille-Luminy
    Institut Pasteur)

  • Yannis Morel

    (Innate Pharma)

  • Ruslan Medzhitov

    (Yale University School of Medicine)

  • Eric Vivier

    (Innate Pharma
    Aix Marseille Université, INSERM, CNRS, Centre d’Immunologie de Marseille-Luminy
    Assistance Publique-Hôpitaux de Marseille)

Abstract

An Amendment to this paper has been published and can be accessed via a link at the top of the paper.

Suggested Citation

  • Olivier Demaria & Stéphanie Cornen & Marc Daëron & Yannis Morel & Ruslan Medzhitov & Eric Vivier, 2019. "Publisher Correction: Harnessing innate immunity in cancer therapy," Nature, Nature, vol. 576(7785), pages 3-3, December.
    • Handle: RePEc:nat:nature:v:576:y:2019:i:7785:d:10.1038_s41586-019-1758-2
    DOI: 10.1038/s41586-019-1758-2
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41586-019-1758-2
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/s41586-019-1758-2?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Qian-Ni Ye & Long Zhu & Jie Liang & Dong-Kun Zhao & Tai-Yu Tian & Ya-Nan Fan & Si-Yi Ye & Hua Liu & Xiao-Yi Huang & Zhi-Ting Cao & Song Shen & Jun Wang, 2024. "Orchestrating NK and T cells via tri-specific nano-antibodies for synergistic antitumor immunity," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    2. Yuedong Guo & Qunqun Bao & Ping Hu & Jianlin Shi, 2023. "Nanomedicine-based co-delivery of a calcium channel inhibitor and a small molecule targeting CD47 for lung cancer immunotherapy," Nature Communications, Nature, vol. 14(1), pages 1-20, December.
    3. Yu-Hsuan Chen & Han-Hsiun Chen & Won-Jing Wang & Hsin-Yi Chen & Wei-Syun Huang & Chien-Han Kao & Sin-Rong Lee & Nai Yang Yeat & Ruei-Liang Yan & Shu-Jou Chan & Kuen-Phon Wu & Ruey-Hwa Chen, 2023. "TRABID inhibition activates cGAS/STING-mediated anti-tumor immunity through mitosis and autophagy dysregulation," Nature Communications, Nature, vol. 14(1), pages 1-20, December.
    4. Eric H. Bent & Luis R. Millán-Barea & Iris Zhuang & Daniel R. Goulet & Julia Fröse & Michael T. Hemann, 2021. "Microenvironmental IL-6 inhibits anti-cancer immune responses generated by cytotoxic chemotherapy," Nature Communications, Nature, vol. 12(1), pages 1-13, December.
    5. Caihua Zhang & Kang Li & Hongzhang Zhu & Maosheng Cheng & Shuang Chen & Rongsong Ling & Cheng Wang & Demeng Chen, 2024. "ITGB6 modulates resistance to anti-CD276 therapy in head and neck cancer by promoting PF4+ macrophage infiltration," Nature Communications, Nature, vol. 15(1), pages 1-23, December.
    6. Katrin Rabold & Martijn Zoodsma & Inge Grondman & Yunus Kuijpers & Manita Bremmers & Martin Jaeger & Bowen Zhang & Willemijn Hobo & Han J. Bonenkamp & Johannes H. W. Wilt & Marcel J. R. Janssen & Lenn, 2022. "Reprogramming of myeloid cells and their progenitors in patients with non-medullary thyroid carcinoma," Nature Communications, Nature, vol. 13(1), pages 1-14, December.
    7. Mengxue Zhou & Jiaxin Wang & Jiaxing Pan & Hui Wang & Lujia Huang & Bo Hou & Yi Lai & Fengyang Wang & Qingxiang Guan & Feng Wang & Zhiai Xu & Haijun Yu, 2023. "Nanovesicles loaded with a TGF-β receptor 1 inhibitor overcome immune resistance to potentiate cancer immunotherapy," Nature Communications, Nature, vol. 14(1), pages 1-18, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:576:y:2019:i:7785:d:10.1038_s41586-019-1758-2. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.